医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

BEVERLY HILLS, Calif.

TOMI™ Environmental Solutions, Inc. (“TOMI” or the “Company”) (OTCQB: TOMZ) announced today that it has signed a sales agreement with the South Korean-based companies KMS I & T Co., Ltd. and Fine C&S Co., representatives of G-Well Group. Representatives from these two companies recently visited TOMI™’s new state-of-the-art facility in Fredrick, Maryland to receive training on the SteraMist™ line of products.

The sales agreement provides that the two companies may sell TOMI™’s SteraMist™ products to G-Well’s extensive client list, representing a cross-section of industries in South Korea including construction, healthcare, pharmaceutical, biosafety, agriculture, transportation and government agencies.

Since the agreement has been in place, four members of the G-Well Group have been trained, an initial order of $120,000 was received and payment was made in full, product was shipped and has cleared customs and is now in efficacy testing at various healthcare facilities.

Additionally, our South Korean sales partners have exhibited and demonstrated SteraMist™ at a trade show with significant interest from many end users.

Joseph So, Managing director of Fine C&S, Ltd stated, “We are excited to add this product to our product line and it will complement our current clients’ needs and improve their disinfection and decontamination requirements.”

Dr. Halden Shane, Chief Executive Officer of TOMI™, stated, “TOMI has added a strategic part of the globe to its expanding list of countries using our SteraMist™ products with the addition of South Korea. I believe having a resource like SteraMist™ in the region will represent a monumental shift in controlling infections and reducing healthcare-associated infections (‘HAIs’) in South Korea. It should become a leading tool in the toolboxes of the infectious disease preventionist and will become part of the country’s Ebola protocol along with an easy and convenient weapon to fight the broad range of recent variation of avian flus that have been affecting the region.”

About TOMI^™ Environmental Solutions, Inc.

TOMI^™ Environmental Solutions, Inc. (OTCQB:TOMZ) is a global bacteria decontamination and infectious disease control company, providing eco-friendly environmental solutions for indoor surface decontamination through manufacturing, sales and licensing of our premier platform of Hydrogen Peroxide based products that uses Binary Ionization Technology (BIT^™) , a state of the art technology for the production of its six-log mist represented by the TOMI™ SteraMist™ brand.

TOMI^™’s products are designed to service a broad spectrum of commercial structures including hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, for food safety in meat and produce processing facilities, military barracks, and athletic facilities. TOMI^™’s products and services have also been used in single-family homes and multi-unit residences.

TOMI^™ also develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, The Restoration Industry Association, Indoor Air Quality Association and The International Ozone Association. For additional product information, visit www.tomiesinc.com or contact us at info@tomiesinc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.